Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects

Clinical trial NCT01608815 · COMPLETED

Trial details

NCT number: NCT01608815
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Salmonella Infections Typhoid Fever Bacterial Infections

Start date: 2012-05-01
Primary completion: 2012-09-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.